19 results
F-10
LMNL
Liminal BioSciences Inc.
12 Nov 19
Registration of securities (Canada)
5:09pm
market, the transparency and availability of trading prices, and the liquidity of such Securities. See “Risk Factors”.
The securities may be sold … . This may affect the pricing of such Securities, in the secondary market, the transparency and availability of trading prices, and the liquidity
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
17 Aug 20
Current report (foreign)
4:14pm
other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government … and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
10 Aug 20
Liminal Biosciences Reports Financial Results for Q2-2020
5:11pm
federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing … access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk
SUPPL
LMNL
Liminal BioSciences Inc.
18 Nov 19
Supplemental materials (foreign)
12:00am
this prospectus. This may affect the pricing of such Securities in the secondary market, the transparency and availability of trading prices … , the transparency and availability of trading prices, and the liquidity of such Securities.
INCOME TAX CONSIDERATIONS
The applicable prospectus supplement
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
17 Aug 20
Current report (foreign)
4:14pm
legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient … cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.
Current
6-K
EX-99.6
a9hcskyoosu
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
F-1
v812kuqp
13 Aug 20
Registration statement (foreign)
5:25pm
424B3
t5ssv inx926w3
30 Sep 20
Prospectus supplement
5:14pm
F-1/A
yasm60
14 Sep 20
Registration statement (foreign) (amended)
4:56pm
6-K
EX-99.1
gz951bn94b6epxhmulha
2 May 23
Notice of Annual Meeting of Shareholders
4:19pm
6-K
EX-99.1
5kbfk7 orx82vq
3 May 22
Notice of Annual Meeting of Shareholders
8:32am
20-F
ffnne7432xq0n
20 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
6k6gnc0hw2m
4 May 21
Notice of Annual and Special Meeting of Shareholders
5:05pm
424B3
fomut7x2 zgqos3g3x5u
12 Nov 20
Prospectus supplement
5:21pm
6-K
EX-99.1
1c9hkof dmk84ul2
30 Apr 20
Notice of Annual and Special Meeting of Shareholders
5:25pm
40FR12B
EX-99.40
mia 2jhix74
12 Nov 19
Initial registration of securities (Canada)
6:11am
40FR12B
EX-99.39
amk1cyiowjyeihri
12 Nov 19
Initial registration of securities (Canada)
6:11am
- Prev
- 1
- Next